5 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
Incyte Corp (INCY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 36,153,684 | $2,871,326 | +8% | 16.49% |
| 2. | Renaissance Technologies Jim Simons | 4,697,633 | $373,086 | +3% | 0.43% |
| 3. | D E Shaw D. E. Shaw | 2,180,378 | $173,166 | -16% | 0.16% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 1,592,809 | $126,501 | +222% | 0.24% |
| 5. | Armistice Capital Steven Boyd | 1,524,000 | $121,036 | -30% | 2.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $73.31 | 175,795 | Large Shareholder, Director | 33,419,055 | 2022-03-10 | Filing | |
| $73.31 | 14,490 | Large Shareholder, Director | 2,941,147 | 2022-03-10 | Filing | |
| $71.95 | 1,017 | Large Shareholder, Director | 33,243,260 | 2022-03-10 | Filing | |
| $71.95 | 84 | Large Shareholder, Director | 2,926,657 | 2022-03-10 | Filing | |
| $71.90 | 25,107 | Large Shareholder, Director | 33,242,243 | 2022-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.96 | 1,248 | Officer | 65,163 | 2022-04-08 | Filing | |
| $82.96 | 881 | Officer | 66,411 | 2022-04-08 | Filing | |
| $84.00 | 21,348 | Officer | 67,292 | 2022-04-08 | Filing | |
| $83.01 | 20,516 | Officer | 67,292 | 2022-04-08 | Filing | |
| $74.19 | 7,375 | Officer | 30,214 | 2022-01-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 2,303,996 | $182,983,362 | 0.07% | |
| 2. | 157,440 | $12,503,885 | 0.01% | |
| 3. | 31,222 | $2,479,651 | 0.01% | |
| 4. | 20,886,756 | $1,658,827 | 0.03% | |
| 5. | 18,093,089 | $1,436,952 | 0.03% |
News See All
Hedge Fund and Insider Trading News: Clifford Asness, Farallon Capital Management, BlueCrest Capital Management, Marshall Wace LLP, Fir Tree Capital Management, Alden Global Capital, Aravt Global LLC, Reservoir Media Inc (RSVR), DoorDash, Inc. (DASH), and More
Hedge fund titan Clifford Asness joined traders in slamming the London Metal Exchange after the platform cancelled trades – a move that may have helped stem losses at a fund that was short the metal...
Did The Smart Money Get Incyte Corporation (INCY) Right?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Fund and Insider Trading News: Catherine Wood, Dan Loeb, Ray Dalio, Millennium Management, Chessica LP, Incyte Corporation (INCY), Verastem, Inc. (VSTM), and More
Billionaire investor Ray Dalio has said the Federal Reserve's tightening of monetary policy in 2022 shouldn't derail the economic expansion, but is likely to weigh heavily on "bubble-type" tech stocks...
Here is What Hedge Funds Think About Incyte Corporation (INCY)
In this article you are going to find out whether hedge funds think Incyte Corporation (NASDAQ:INCY) is a good investment right now.
Hedge Funds Are Nibbling On Incyte Corporation (INCY)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Why These 5 Stocks Are on the Move on Wednesday
5. FedEx Corporation (NYSE:FDX) is down around 8% after FedEx Corporation (NYSE:FDX) reported $4.37 in adjusted earnings per share and $22 billion in revenue for the first quarter of fiscal 2022.
Hedge Funds Are Selling Incyte Corporation (INCY)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
5 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood.
Is INCY Stock A Buy or Sell?
At Insider Monkey, we pore over the filings of nearly 887 top investment firms every quarter, a process we have now completed for the latest reporting period.
Billionaire Hedge Funds
